{
  "chapter": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors",
  "questions": [
    {
      "q_no": 1,
      "question": "Which type of pancreatic neoplasm most commonly arises in the tail of the pancreas?",
      "options": {
        "A": "Serous cystadenoma.",
        "B": "Mucinous cystadenoma",
        "C": "VIPOMA",
        "D": "Adenocarcinoma pancreas"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) VIPOMA Explanation: Common site for vasoactive intestinal peptide tumor (VIPOMA) is the tail of the pancreas. Location Tumors Head Adenocarcinoma pancreas (Option D ruled out) Serous cystadenoma (Option A ruled out) Intraductal Papillary Mucinous neoplasm Somatostatinoma PPOMA (Pancreatic Polypeptide cell tumor) Body and tail Glucagonoma Mucinous cystadenoma (Option B ruled out) Tail VIPOMA (Vasoactive intestinal peptide tumor) (Option C) Equal distribution in body, head and tail. Insulinoma Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 1281 Sabiston Textbook of Surgery, 21st Edition, Page 1547 SRB’s Manual of Surgery, 6th Edition, Page 702-704 https://www.ncbi.nlm.nih.gov/books/NBK551613/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 2,
      "question": "A 60-year-old male presents with recurrent episodes of abdominal pain and is found to have jaundice. An ERCP is performed, revealing thick mucus extruding through the ampulla of Vater. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Pseudocyst",
        "B": "Main duct IPMN",
        "C": "Chronic pancreatitis",
        "D": "Pancreatic adenocarcinoma"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Main duct IPMN (Intraductal Papillary Mucinous Neoplasm) Explanation: The presence of thick mucus extruding through the ampulla of Vater during an ERCP is diagnostic of a main duct IPMN, a mucinous tumor that produces large amounts of mucus. Diagnostic significance of thick mucus during ERCP Finding: Thick mucus extruding through the ampulla of Vater during ERCP Diagnostic of: Main duct IPMN (intraductal papillary mucinous neoplasm) (Option B) Key Points: IPMNs : Mucinous tumors in the pancreas Characterized by mucus production Ampulla of Vater : Opening where the common bile duct and pancreatic duct empty into the duodenum Main Duct IPMN : Develops within the main pancreatic duct Produces large amounts of mucus ERCP (Endoscopic Retrograde Cholangiopancreatography) : Uses a side-viewing endoscope Visualizes and injects contrast into biliary and pancreatic ducts Thick mucus from IPMN may be seen extruding from the ampulla of Vater (image below). Further Investigation: Imaging : MRCP (Magnetic Resonance Cholangiopancreatography) - Investigation of choice EUS (Endoscopic Ultrasound) Fluid Analysis : CEA (Carcinoembryonic Antigen) and amylase levels are increased Cytology Pseudocyst (Option A): While pseudocysts can be associated with mucus, they do not typically cause mucus extrusion through the ampulla of Vater during ERCP. Chronic pancreatitis (Option C): It is characterized by inflammation and fibrosis, not mucus production. Pancreatic adenocarcinoma (Option D): These are solid, scirrhous tumors, characterized by neoplastic tubular glands, which do not produce thick mucus that extrudes through the ampulla of Vater during an ERCP.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 3,
      "question": "What is the most common complication and common cause of death in a patient post pancreaticoduodenectomy?",
      "options": {
        "A": "Delayed gastric emptying, Pulmonary complication",
        "B": "Anastomosis leak, Pulmonary complication",
        "C": "Delayed gastric emptying, Perforated bowel obstruction",
        "D": "Anastomosis leak, Perforated bowel obstruction"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Delayed gastric emptying, Pulmonary complication Explanation: The most common complication of pancreatoduodenectomy is delayed gastric emptying while the most common cause of death is pulmonary complications. Pancreatoduodenectomy: Also known as Whipple’s procedure, involves the excision of the pancreatic head, duodenum, distal stomach, gallbladder, and distal bile duct. The most common complication of pancreatoduodenectomy is delayed gastric emptying. The most common cause of death is pulmonary complications. Complication Frequency (%) Delayed gastric emptying (Option A) 18 Pancreas fistula 12 Wound infection 7 Intraabdominal abscess 6 Cardiac events 3 Bile leak 2 Overall reoperation 3 Anastomosis leak is another common complication of pancreatoduodenectomy and can result in the formation of pancreatic fistula severely affecting the mortality and morbidity of the patient (Options B, C, and D) . Reference: Sabiston Textbook of Surgery, 21st Edition, Page 1558 https://www.nature.com/articles/s41598-022-26814-7 Postoperative morbidity following Whipple’s procedure",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 4,
      "question": "A 48-year-old perimenopausal woman presents with abdominal discomfort. Imaging reveals a multilocular cyst with thick walls located in the pancreatic tail. Fine-needle aspiration of the cyst fluid shows high carcinoembryonic antigen levels exceeding 400 ng/mL, with normal amylase levels. What is the most likely diagnosis?",
      "options": {
        "A": "Pancreatic pseudocyst",
        "B": "Serous cystadenoma",
        "C": "Mucinous cystic neoplasm",
        "D": "Adenoma of the Ampulla of Vater"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Mucinous cystic neoplasm (MCN) Explanation: Cyst characteristics (multilocular cyst with thick walls in the pancreatic tail), and high CEA levels strongly point towards the diagnosis of MCN. It is commonly seen in perimenopausal women. Mucinous cystic neoplasms (MCNs) and adenomas represent distinct types of cystic pancreatic tumors with varying malignant potential. Mucinous Cystic Neoplasms (MCNs): (Option C) These tumors typically occur in perimenopausal women Appear as multilocular cysts with thick walls, predominantly located in the pancreatic body or tail. They are characterized by the presence of an ovarian-type stroma, which distinguishes them from other cystic pancreatic lesions. Adenomas of the Ampulla of Vater: (Option D ruled out) These adenomas, frequently encountered as polypoid submucosal masses covered by a smooth epithelium, are primarily diagnosed through endoscopy. Initially benign, can become malignant with an increase in size Imaging: CT and ultrasound for structure visualization, cannot definitively diagnose. Fluid Analysis: Fine-needle aspiration (FNA) of the cyst fluid, preferably using EUS guidance, allows for detailed analysis. Key parameters in fluid analysis include: Carcinoembryonic Antigen (CEA) Levels : High CEA levels, typically exceeding 400 ng/mL, strongly indicate a mucinous neoplasm. Amylase Levels: Elevated amylase levels are characteristic of pseudocysts, although certain tumors connected to the pancreatic duct might also exhibit elevated levels. Cytology: Inflammatory cells, commonly found in pseudocysts, or atypical cells, which suggest a neoplasm. Factor MCNs Adenomas (Option D ruled out) Pseudocysts (Option A ruled out) Serous cystadenoma (Option B ruled out) Demographics Perimenopausal women Varied History of pancreatitis Older woman Location Pancreatic body or tail Ampulla of Vater Anywhere in the pancreas Tail of pancreas Characteristics Multilocular cysts, thick walls Polypoid submucosal masses Cysts with elevated amylase Lobular, hypodense lesion with multiple small cysts Key Diagnostic Tool CEA levels (>400 ng/mL) Endoscopy History, imaging, amylase levels CECT: Central stellate scar, central sunburst calcification Reference: Bailey & Love’s Short Practice of Surgery, 28th Edition, Page 1276, 1281, 1282",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 5,
      "question": "A 45-year-old male has a history of recurrent peptic ulcers and severe abdominal pain. Despite the use of proton pump inhibitors, his symptoms persist. Endoscopic examination reveals small nodules in the medial wall of the duodenum. His family history is significant for multiple endocrine neoplasia type I. Which of the following statements is most likely true regarding his condition?",
      "options": {
        "A": "The tumors are most commonly found in the tail of the pancreas.",
        "B": "The condition is curable with surgical removal of the primary tumor.",
        "C": "The patient's gastrinoma is likely located within the gastrinoma triangle.",
        "D": "The use of proton pump inhibitors has made diagnosis of this condition easier"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) The patient's gastrinoma is likely located within the gastrinoma triangle. Zollinger- Ellison syndrome, in which gastrinomas are predominant. Gastrinomas are often located within the gastrinoma triangle, defined by cystic duct/common bile duct, duodenum, and pancreas. Zollinger-Ellison syndrome: Aspect Details Tumor Location Duodenal loop, Pancreas (head) (Option A ruled out) Causes Persistent peptic ulceration Historical Recognition Severe peptic ulcers unresponsive to surgery pre-PPI era. The use of proton pump inhibitors has made the condition controllable but harder to recognize. (Option D ruled out) Types Sporadic, MEN type I (with parathyroid adenoma) Common Locations Gastrinoma Triangle (cystic duct/common bile duct, duodenum, pancreas) (Option C) Detection Small nodules in duodenal wall, endoscopic and surgical inspection needed Course Indolent for some malignant gastrinomas Treatment Palliative liver resection, liver transplantation, surgical removal for palliation in MEN type I as they are incurable. (Option B ruled out) Prognosis Worse for tumors outside gastrinoma triangle Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 1179, 1180",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 6,
      "question": "A 70-year-old female patient is evaluated for a pancreatic cystic mass. The CT scan shows a lobular, hypodense lesion with multiple small cysts, a central hyperdense scar, and scattered \"sunburst\" calcifications. Based on these findings, what is the most likely diagnosis?",
      "options": {
        "A": "Mucinous cystic neoplasm",
        "B": "Pancreatic pseudocyst",
        "C": "Serous cystadenoma",
        "D": "Intraductal papillary mucinous neoplasm"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Serous cystadenoma Explanation: The CT features described, lobular hypodense lesion with a central hyperdense scar and \"sunburst\" calcifications , are characteristic of a serous cystadenoma. Serous Cystic Neoplasms (SCNs): Characteristics : Benign tumors with multiple small cysts resembling bubble wrap. Commonly found in older women. Management : Surgery : Consider if a solid mass is present or if surgical intervention is indicated. Monitoring : For patients unfit for surgery or without surgical indications, use clinical evaluations, serum CA 19-9 tests, MRCP, and EUS. CT Findings of Serous Cystadenomas: (Option C) Feature Description Shape and Density Lobular shape; hypodense due to high water content. Calcifications Present in up to 30%; can show a \" sunburst \" pattern. Central Fibrous Scar Hyperdense, stellate pattern, enhances with contrast. Enhancement Patterns Hypervascular; fibrous portions enhance post-contrast fluid density in less fibrous areas. Oligocystic and Macrocystic Variants Oligocystic patterns may mimic mucinous neoplasms; macrocystic variants may resemble pseudocysts or mucinous cysts. Differentiation Challenging to distinguish from other cystic pancreatic neoplasms; an MRI may be needed. Mucinous cystic neoplasms (Option A): MCNs are seen in perimenopausal women, as multilocular thick-walled cysts in the pancreatic body or tail, and histologically, contain an ovarian-type stroma. They can turn malignant. Pancreatic pseudocysts (Option B): Usually lack central scarring and specific calcification. Intraductal papillary mucinous neoplasm (IPMN) (Option D): IPMNs are more common in older men and mostly involve the pancreatic head. Thick mucus is seen extruding from the ampulla on ERCP, which is diagnostic of IPMN. It has a greater tendency to prove malignant.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 7,
      "question": "What is the most common site of gastrinoma in patients with Zollinger–Ellison syndrome",
      "options": {
        "A": "Stomach",
        "B": "Pancreas",
        "C": "Duodenum",
        "D": "Liver"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Duodenum Explanation: Majority of gastrinomas are located in the duodenum in both sporadic cases (50% to 88% of cases) and those associated with MEN 1 (70% to 100% of cases). Gastrinoma Pathology Sporadic Disease: Tumors mainly in duodenum (50% to 88%) (Option C) Small (<5 mm) and multiple MEN 1: Tumors in the duodenum 90% occur within the ‘gastrinoma triangle’: Bounded by the pancreas neck/body junction, second/third parts of the duodenum, and cystic/common bile ducts junction. Gastrinoma Overview: Category Details Definition Fulminating ulcer diathesis, recurrent ulceration, non- β islet cell tumors (gastrinoma) Incidence 0.5-4 per million, 0.1% of duodenal ulcers, 20-25% associated with MEN Rarely occur in the stomach (Option A ruled out) , peripancreatic lymph nodes, liver (Option D ruled out) , bile duct, ovary, and heart Pancreatic gastrinoma comprises 25% of the cases (Option B ruled out) Pathology Sporadic (duodenum, small, multiple), MEN 1 (duodenum, gastrinoma triangle) Clinical Peptic ulcers, diarrhea, abdominal pain, high alcohol use history Diagnosis Elevated FSG (fasting serum gastrin), gastric pH <2, secretin provocation test, MEN 1 screening, localization studies Treatment Surgery (sporadic without metastases, MEN 1 >2 cm) Medical (PPI, SSA, locoregional therapy)",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 8,
      "question": "Among the following, which option correctly describes the most common location of origin of insulinoma in the pancreas?",
      "options": {
        "A": "Head > Body > Tail",
        "B": "Body = Tail > Head",
        "C": "Tail > Body > Head",
        "D": "Head = Body = Tail"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Head = Body = Tail Explanation: Common sites for origin of insulinoma in pancreas are the head, body and tail of the pancreas equally. Location Tumors Head Carcinoma pancreas Serous cystadenoma Intraductal Papillary Mucinous neoplasm Somatostatinoma PPOMA (Pancreatic Polypeptide cell tumor) Body and tail Glucagonoma Mucinous cystadenoma Tail VIPOMA (Vasoactive Intestinal Peptide tumor) Equal distribution in body, head and tail. Insulinoma Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 1281 Sabiston Textbook of Surgery, 21st Edition, Page 1547 SRB’s Manual of Surgery, 6th Edition, Page 702-704 https://www.ncbi.nlm.nih.gov/books/NBK551613/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 9,
      "question": "Which type of pancreatic neoplasm most commonly arises in the body and tail of the pancreas?",
      "options": {
        "A": "Serous cystadenom",
        "B": "Mucinous cystadenoma",
        "C": "Intraductal papillary mucinous neoplasm",
        "D": "Adenocarcinoma pancreas"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Mucinous cystadenoma. Explanation: The body and tail of the pancreas are the most common site for mucinous cystadenoma. Table shows the common location of the tumors of the pancreas: Location Tumors Head Adenocarcinoma pancreas (Option D ruled out) Serous cystadenoma (Option A ruled out) Intraductal Papillary Mucinous neoplasm (Option C ruled out) Somatostatinoma PPOMA (Pancreatic Polypeptide cell tumor) Body and tail Glucagonoma Mucinous cystadenoma (Option B) Tail VIPOMA ( Vasoactive intestinal peptide tumor) Equal distribution in body, head and tail. Insulinoma Reference: Bailey & Love's Short Practice of Surgery, 28th Edition, Page 1281 Sabiston Textbook of Surgery, 21st Edition, Page 1547 SRB’sManual of Surgery, 6th Edition, Page 702-704 https://www.ncbi.nlm.nih.gov/books/NBK551613/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 10,
      "question": "A 55-year-old male presents with jaundice, weight loss, and epigastric pain. Imaging reveals a mass in the head of the pancreas. Which of the following conditions is most likely responsible for these symptoms?",
      "options": {
        "A": "Chronic Pancreatitis",
        "B": "Ductal Adenocarcinoma",
        "C": "Solid Pseudopapillary Neoplasm",
        "D": "Intraductal Papillary Mucinous Neoplasm"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Ductal Adenocarcinoma Explanation: Ductal Adenocarcinoma is the most common malignancy of the pancreas, most commonly occurring in the head region. It typically presents with symptoms like jaundice (due to bile duct obstruction), weight loss, and epigastric pain. Imaging often reveals a mass in the head of the pancreas, making it the most likely diagnosis in this clinical scenario. Common Conditions in the Head of the Pancreas: Ductal Adenocarcinomas Most prevalent condition in the head of the pancreas. Can occur throughout the pancreas but predominantly originates in the head. Other Conditions Commonly Found in the Head of the Pancreas: Chronic Pancreatitis (Option A ruled out) Affects the entire pancreas, but pain is often concentrated in the head if it is the primary disease site. Intraductal Papillary Mucinous Neoplasms (IPMNs) (Option D ruled out) Frequently found in the head of the pancreas. Characterized by mucus production, observable during ERCP. Solid Pseudopapillary Neoplasms (Option C ruled out) Rare malignant lesions, more common in the head of the pancreas. More commonly seen in women of childbearing age. Ampullary Tumors Originate from the ampulla of Vater or the distal common bile duct. Present as a mass in the head of the pancreas due to the ampulla of Vater's location. Include adenomas and adenocarcinomas, often mistaken for pancreatic head tumors due to proximity. Reference: Bailey & Love’s Short Practice of Surgery, 28th Edition, Page 1281",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 11,
      "question": "A patient with a suspected intraductal papillary mucinous neoplasm (IPMN) has elevated serum CA 19-9 levels. What does this finding most likely suggest?",
      "options": {
        "A": "The IPMN is benign and does not require surgical intervention",
        "B": "The IPMN is likely malignant or has high-grade dysplasia",
        "C": "The IPMN is a branch duct type and requires conservative management",
        "D": "The IPMN is likely malignant and surgery is contraindicated"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) The IPMN is likely malignant or has high-grade dysplasia Explanation: Elevated CA 19-9 levels are often associated with malignancy or high-grade dysplasia in IPMNs, suggesting a need for further evaluation and potentially surgery. Intraductal Papillary Mucinous Neoplasms (IPMNs) Location: Predominantly in the head of the pancreas . More common in older men . Pathology: The whole pancreatic duct is distended with the mucin secreted and may cause obstruction Types: Main duct IPMN (High risk of malignancy) Side branch IPMN (Low risk of malignancy) Mixed IPMN Investigations: MRCP is the first line and investigation of choice. CT in MRI contraindicated patients. EUS (endoscopic ultrasound) with FNA (Fine needle aspiration) of the cyst fluid for analysis: Mucinous content Increased CEA and amylase levels On endoscopy, visualization of thick mucus extruding from the ampulla is diagnostic of a main duct IPMN. Risk of malignant transformation IN IPMN: Main duct 5–9 mm Enhancing mural nodule <5 mm Thickened, enhancing cyst wall BD-IPMN >3 cm Lymphadenopathy Pancreatitis Increased serum CA 19–9 (Option B) Cyst growth >5 mm over 2 years Management Algorithm: Aspect Details Management Pathways Surgical Indications : Confirmed carcinoma/high-grade dysplasia, solid mass, jaundice, mural nodules, significant duct dilation. Non-Surgical Management : For unsuitable candidates or non-surgical criteria, with regular monitoring (clinical, CA 19-9, imaging). Surgical Options Pylorus-Preserving Pancreatoduodenectomy (PPPD) : For pancreatic head tumors. Distal Pancreatectomy : For body/tail tumors. Total Pancreatectomy : For multifocal tumors, unsafe bowel anastomosis and whole duct involvement. Reference: Bailey &Love’s Short Practice of Surgery, 28th Edition, Page 1281-1287 https://www.ncbi.nlm.nih.gov/books/NBK507779/ Sabiston Textbook of Surgery, 21st Edition, Page 1548, 1549",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 12,
      "question": "In a patient with a pancreatic cyst, peripheral eggshell calcification on CT is:",
      "options": {
        "A": "Common in benign cysts and easily detected.",
        "B": "Easily detected and a definitive marker of malignancy.",
        "C": "Difficult to detect but highly indicative of malignancy in mucinous cystic neoplasms.",
        "D": "Exclusively associated with pancreatic pseudocysts, not with malignancy."
      },
      "correct_answer": "C",
      "explanation": "neoplasms. Correct Answer: C) Difficult to detect but highly indicative of malignancy in mucinous cystic neoplasms. Explanation: Peripheral eggshell calcification is subtle on CT but a strong indicator of malignancy in mucinous cystic neoplasms. Peripheral Eggshell Calcification in Mucinous Cystic Neoplasms (MCNs) of the Pancreas: Aspect Details Calcification Type Peripheral eggshell (Option C) Imaging Modality CT scan (challenging to detect) (Options A & B ruled out) Predictive Value High for malignancy (Option D ruled out) Typical Patient Middle-aged females Cyst Characteristics Unilocular or multilocular macrocysts Possible Imaging Findings Thickened wall, vascular involvement Clinical Action Further assessment and potential surgery Reference: Sabiston Textbook of Surgery, 21st Edition, Page 1547 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051074/",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Hepatobiliary_Pancreatic_Surgery-Pancreatic_Tumors_Q12_exp.png",
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 13,
      "question": "A 45-year-old patient presents with chronic watery diarrhea. Laboratory tests reveal elevated levels of vasoactive intestinal peptide (VIP) > 150 pg/ml, achlorhydria, and hypokalemia. Imaging studies show a solitary mass in the body of the pancreas. What is the treatment of choice in this condition?",
      "options": {
        "A": "Initiate high-dose corticosteroid therapy with Prednisolone",
        "B": "Start treatment with Octreotide",
        "C": "Perform a distal pancreatectomy",
        "D": "Begin broad-spectrum antibiotic therapy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Perform a distal pancreatectomy Explanation: The described scenario is that of VIPOMA . Distal pancreatectomy is the treatment of choice for VIPOMA, especially when the tumor is solitary and located in the body or tail of the pancreas. VIPOMA Origin and Classification: Source: D2 cells of the pancreas. Alternative Names: Pancreatic cholera, Verner-Morrison syndrome, weak-tea syndrome. Nature: Usually malignant. Clinical Features (WDHA Syndrome) Watery diarrhea. Hypokalemia. Achlorhydria. Biochemical Markers Vasoactive Intestinal Peptide (VIP): Secretion > 150 pg/ml. Location Typically found in the body and tail of the pancreas. Treatment Surgical: Distal pancreatectomy is the treatment of choice when the tumor is solitary and located in the body or tail of the pancreas (Option C) Medications: Prednisolone: Controls diarrhea. (Option A ruled out) Octreotide: Useful in managing symptoms. (Option B ruled out) Begin broad-spectrum antibiotic therapy (Option D): Antibiotics are not indicated in the management of VIPOMA, as the condition is related to a tumor rather than an infection. Reference: SRB Manual of Surgery, 6th Edition, Page 704",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 14,
      "question": "A 58-year-old female presents with diarrhea, weight loss, and itchy lesions around the mouth and vagina. Physical examination reveals a rash as shown in the image below. On evaluation, she has diabetes, and imaging studies indicate a large pancreatic mass. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Gastrinoma",
        "B": "Insulinoma",
        "C": "Glucagonoma",
        "D": "VIPoma"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Glucagonoma Explanation: The above symptoms of weight loss, diarrhea, stomatitis and vulvovaginitis with the characteristic rash suggestive of necrolytic migratory erythema , along with large pancreatic mass points towards the diagnosis of glucagonoma. Aspect Details Origin Alpha cells of the pancreas Common Locations Body and tail of the pancreas Size 5-10 cm Prevalence Sporadic; 17% with MEN type II syndrome Gender More common in females Malignancy 80% malignant; 80% spread to liver Symptoms Necrolytic migratory erythema, diabetes, diarrhea, weight loss, stomatitis, anemia, amino acid deficiency, vulvovaginitis Diagnostic Tests MRI, CT scan, Endosonography, Angiogram, Serum glucagon levels (>50 pmol/L) Treatment Anemia and deficiency correction, IV amino acids, DVT prevention, Distal pancreatectomy, Whipple’s/total pancreatectomy, Enucleation, Dacarbazine Gastrinoma (Option A): Typically associated with Zollinger-Ellison syndrome, presenting with recurrent peptic ulcers rather than necrolytic migratory erythema. Insulinoma (Option B): Characterized by hypoglycemia and hyperinsulinemia, not typically associated with necrolytic migratory erythema. VIPoma (Option D): Associated with WDHA syndrome (Watery Diarrhea, Hypokalemia, Achlorhydria) and not with necrolytic migratory erythema. Reference: SRB Manual of Surgery, 6th Edition, Pages 703, 704",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Hepatobiliary_Pancreatic_Surgery-Pancreatic_Tumors_Q14_q.png",
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 15,
      "question": "A 45-year-old woman with a family history of cancer presents for a routine check-up. Her mother and maternal aunt both had pancreatic cancer. Genetic testing reveals a gain-of-function mutation in the PRSS1 gene. Which of the following factors contributes the most to her increased risk of developing pancreatic cancer?",
      "options": {
        "A": "Chronic pancreatitis",
        "B": "Germline BRCA2 mutation",
        "C": "Lynch syndrome",
        "D": "Hereditary pancreatitis"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Hereditary pancreatitis Explanation: Hereditary pancreatitis is associated with a gain-of-function mutation in the PRSS1 gene and increases the risk of pancreatic cancer by 50-70 times. Genetic Risk Factors for Pancreatic Cancer: Family History : Two first-degree relatives with pancreatic cancer increase risk by 18-57 times. Germline BRCA2 Mutations : Present in some rare high-risk families. (Option B ruled out) Hereditary Pancreatitis : 50-70 times increased risk. (Option D) Chronic Pancreatitis : 5-15 times increased risk. (Option A ruled out) Other Syndromes : Lynch Syndrome (HNPCC) (Option C ruled out) Ataxia Telangiectasia Peutz-Jeghers Syndrome Familial Breast-Ovarian Cancer Syndrome Familial Atypical Multiple Mole Melanoma Familial Adenomatous Polyposis (risk of ampullary/duodenal carcinoma) Hereditary Pancreatitis: Inheritance : Autosomal dominant with 80% penetrance. Mutations : PRSS1 : Gain-of-function mutation on chromosome 7, producing degradation-resistant trypsin. SPINK1 : Loss-of-function mutation predisposes to idiopathic pancreatitis. CFTR : Mutations linked to idiopathic chronic pancreatitis. Cancer Risk : Significantly increased, especially with tobacco use. Other Risk Factors: Demographic factors Environmental/Lifestyle factors Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 1277, 1278, 1281",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 16,
      "question": "Which diagnostic finding is most indicative of an insulinoma?",
      "options": {
        "A": "Elevated serum glucose levels",
        "B": "Low C-peptide levels",
        "C": "Elevated serum insulin levels during hypoglycemia",
        "D": "Hyperinsulinemic response to oral glucose tolerance test"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Elevated serum insulin levels during hypoglycemia Explanation: The most indicative diagnostic finding for an insulinoma is elevated serum insulin levels during hypoglycemia. This confirms that hypoglycemia is due to endogenous insulin production, which is characteristic of insulinoma. Category Details Definition A rare, typically benign tumor of the pancreatic islet cells that produces excess insulin. Clinical Features Whipple's Triad- Documented low blood glucose levels during symptomatic episodes Relief of symptoms upon administration of glucose Symptoms often occur during fasting or after exercise Symptoms of hypoglycemia (e.g., sweating, palpitations, confusion, visual disturbances, seizures) Diagnosis Gold-standard test for diagnosing insulinoma is a 72-hour fast. (Option C) Combination of plasma glucose < 55 mg/dL + insulin level ≥ 3 microUnits/mL + C peptide level ≥ to 0.6 ng/mL + proinsulin ≥ 5 pmol/L, + negative sulfonylurea level indicates that the hypoglycemia induction is by hyperinsulinemia Insulin/glucose ratio > 0.4 is diagnostic Imaging: CT, MRI, EUS Management Surgical resection is the treatment of choice Medical management with diazoxide or octreotide for non-surgical candidates or unresectable tumors Elevated serum glucose levels (Option A) : Insulinomas cause hypoglycemia, not elevated glucose levels. Low C-peptide levels (Option B) : Insulinomas typically show elevated C-peptide levels, indicating endogenous insulin production. Low C-peptide levels would suggest exogenous insulin administration. Hyperinsulinemic response to oral glucose tolerance test (Option D) : While insulinomas cause excessive insulin production, the diagnosis is confirmed by measuring insulin levels during hypoglycemic episodes, not after an oral glucose load. Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 906 https://www.ncbi.nlm.nih.gov/books/NBK544299/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 17,
      "question": "Which of the following statements is true regarding neuroendocrine tumors of the pancreas?",
      "options": {
        "A": "The most common non-functional neuroendocrine tumor of the pancreas is insulinoma",
        "B": "Somatostatin receptor scintigraphy is used for the localization of NETs",
        "C": "The most common site of metastasis is the lungs",
        "D": "Functional NETs are diagnosed at a later stage and have poor prognosis"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Somatostatin receptor scintigraphy is used for the localization of NETs pancreatic NETs The most prevalent non-functional neuroendocrine tumor of the pancreas is polypeptide cell tumor (PPOMA). The most common functional neuroendocrine tumor of the pancreas is insulinoma. (Option A ruled out) The most common functional and malignant neuroendocrine tumor of the pancreas is a gastrinoma. It is also the most common in MENS syndrome. The most common site of metastasis is the liver. (Option C ruled out) Neuroendocrine tumors are symptomatic due to the secretion of active substances. Consequently, patients are: Symptomatic at an early stage and diagnosed at an early stage . (Option D ruled out) Early diagnosis improves outcomes Diagnosis: Laboratory measurement of active substances or its by products. Somatostatin receptor scintigraphy (SRS) is used for the localization of NETs. (Option B) Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 905 Insulinoma - StatPearls - NCBI Bookshelf Somatostatin Receptor Scintigraphy Findings in a Patient with Metastatic Gastrinoma and MEN 1 Syndrome - PMC https://www.ncbi.nlm.nih.gov/books/NBK441842/#:~:text=Duodenal%20gastrinomas%20are%20 usually%20less%20than%201%20cm%2C%20multiple%2C%20occur%20predominantly%20in%20the%20first%2 0part%20of%20the%20duodenum%2C%20and%20comprise%20approximately%2050%25%20to%2088%25%20o f%20gastrinomas%20associated%20with%20sporadic%20ZES%20and%2070%25%20to%20100%25%20of%20ga strinomas%20associated%20with%20MEN%201 . https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871954/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 18,
      "question": "Which surgical procedure is characterized by the resection of the pancreatic head while preserving the stomach and pylorus?",
      "options": {
        "A": "Whipple procedure",
        "B": "Distal pancreatectomy",
        "C": "Longmire Traverso procedure",
        "D": "Total pancreatectomy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Longmire Traverso procedure Explanation: Longmire Traverso procedure is also called Pylorus Preserving Pancreaticoduodenectomy. Pylorus-Preserving Pancreaticoduodenectomy (PPPD): Preserves the gastric antrum, pylorus, and proximal duodenum, anastomosing the duodenum to the jejunum to maintain gastrointestinal continuity. Indications: Malignant or premalignant neoplasms in the pancreatic head or periampullary structures (bile duct, ampulla, or duodenum) Advantages of PPPD compared to conventional pancreaticoduodenectomy are: Reduced incidence of postoperative complications like dumping syndrome, marginal ulceration, and bile reflux gastritis. Improved gastrointestinal function due to preservation of the gastric antrum and pylorus in PPPD leading to more physiological gastric emptying. Reduced operative time and blood Loss Lower perioperative mortality In pylorus-preserving pancreaticoduodenectomy (PPPD), the sequence of anastomoses typically follows these steps: 1st - Pancreaticojejunostomy 2nd - Hepaticojejunostomy 3rd - Duodenojejunostomy Reference: https://www.uptodate.com/contents/pylorus-preserving-pancreaticoduodenectomy?search=whipple%20p rocedure&source=search_result&selectedTitle=1~60&usage_type=default&display_rank=1",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 19,
      "question": "A patient is scheduled to undergo a Whipple procedure for the treatment of pancreatic cancer. The surgeon needs to perform anastomosis to reconstruct the digestive tract after removing the affected tissues. In which sequence are the anastomoses typically performed during a Whipple procedure? → Pancreaticojejunostomy → Gastrojejunostomy → Hepaticojejunostomy → Gastrojejunostomy → Pancreaticojejunostomy → Hepaticojejunostomy → Gastrojejunostomy → Hepaticojejunostomy",
      "options": {
        "A": "Hepaticojejunostomy",
        "B": "Pancreaticojejunostomy",
        "C": "Gastrojejunostomy",
        "D": "Pancreaticojejunostomy"
      },
      "correct_answer": "B",
      "explanation": "→ Hepaticojejunostomy → Gastrojejunostomy Correct Answer: B) Pancreaticojejunostomy → Hepaticojejunostomy → Gastrojejunostomy pancreaticojejunostomy, followed by the hepaticojejunostomy, and finally the gastrojejunostomy. This order allows for proper reconstruction of the digestive system following the removal of the affected tissues. Whipple’s procedure (Pancreaticoduodenectomy) Structures removed: Head of the pancreas, the first part of the small intestine (duodenum), the gallbladder, and a portion of the bile duct. Types: Pylorus-Preserving Whipple Procedure (Preferred) Non–Pylorus-Preserving Whipple Procedure Indications Pancreatic Cancer: Commonly treated with Whipple if cancer is localized to the head of the pancreas. Chronic Pancreatitis: when uncontrolled by medical management. Tumors in Pancreas/Surrounding Areas: Includes duodenum, distal bile duct, and ampulla of Vater. Procedure Steps Tumor Assessment: Explore abdomen to assess tumor size, location, and spread. Resection: Remove head of pancreas, duodenum, gallbladder, and part of bile duct; this may include partial stomach resection. Lymph Node Dissection: Remove and examine nearby lymph nodes. Reconstruction Pancreaticojejunostomy: Connect remaining pancreas to jejunum. Hepaticojejunostomy: Connect common bile duct to jejunum. Gastrojejunostomy: Connect stomach to jejunum. Anastomosis Principles Tension-Free Connection: Achieve mucosa-to-mucosa connection for healing. Order of Anastomoses: Pancreaticojejunostomy → Hepaticojejunostomy → Gastrojejunostomy Stent Placement: May use internal/external stents for small ducts. Complications Pancreatic Fistula: Major issue; managed with somatostatin analogues. Delayed Gastric Emptying Bleeding, wound infection Reoperation, increased mortality Dumping/Bile Reflux: Common after non-pylorus-preserving Whipple; pylorus-preserving method has uncertain benefits.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 20,
      "question": "A 65-year-old male presents with jaundice, dark urine, and weight loss over the past two months. Courvoisier's Sign is positive on physical examination. What is the next best step in the management of this patient to both visualize pancreatic and biliary ducts, and tissue sampling?",
      "options": {
        "A": "Computed Tomography",
        "B": "Endoscopic Ultrasonography",
        "C": "Endoscopic Retrograde Cholangiopancreatography",
        "D": "Diagnostic Laparoscopy"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Endoscopic Retrograde Cholangiopancreatography (ERCP) Explanation: ERCP is used for visualizing bile and pancreatic ducts and can obtain brush cytology or biopsy samples but is less effective at detecting small pancreatic tumors compared to EUS. Imaging techniques and their usefulness: Technique Uses and key features CT Scan (Option A) First choice for diagnosing pancreatic cancer. Detects mass, duct dilation, and pancreatic atrophy. Detection of metastasis. MRI/MRCP (Magnetic Resonance Cholangiopancreatography) Complementary to CT for additional information. MRCP identifies biliary obstruction and pancreatic duct issues. Does not show calcification visible on CT. ERCP (Endoscopic Retrograde Cholangiopancreatography) (Option C) Visualizes pancreatic and biliary ducts. Allows for tissue sampling. Key signs: Narrowing of ducts, double duct sign. EUS (Endoscopic Ultrasound) (Option B) Useful when CT does not show a tumor. Assesses vascular invasion and differentiates cystic tumors from pseudocyst Additional Procedures: Diagnostic Laparoscopy : (Option D ruled out) Uses: Identifies small peritoneal and liver metastases to assess resectability Not suitable for visualisation of the pancreatic and biliary ducts.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxsurgery/Hepatobiliary_Pancreatic_Surgery-Pancreatic_Tumors_Q20_exp.png",
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 21,
      "question": "A 55-year-old man with no history of obesity or a family history of diabetes is recently diagnosed with diabetes mellitus. He also reports vague upper abdominal discomfort, significant weight loss, and mild jaundice. Which of the following findings on physical examination would most likely suggest a diagnosis of pancreatic cancer?",
      "options": {
        "A": "Tender and enlarged gallbladder",
        "B": "Hepatomegaly with jaundice",
        "C": "Courvoisier's sign",
        "D": "Murphy’s sign"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Courvoisier's sign (palpable, non-tender gallbladder) Explanation: Courvoisier's sign is the presence of a palpable, non-tender gallbladder , which strongly suggests malignant obstruction of the bile duct , typically from a pancreatic head tumor. This is a classic sign associated with pancreatic cancer. Pancreatic carcinomas are highly aggressive tumors, more than 85% of it being ductal adenocarcinomas. Symptoms: Jaundice secondary to obstruction is the most common symptom Characteristically painless, but may be associated with nausea and epigastric discomfort Pruritus, dark urine and pale stools with steatorrhea Weight loss Signs: Courvoisier’s sign - palpable, non-tender gallbladder (Option C) Palpable liver and ascites Diabetes mellitus depending on the location of tumor Tender and enlarged gallbladder (Option A): A tender gallbladder is more suggestive of acute cholecystitis or gallstone disease rather than pancreatic cancer. Hepatomegaly with jaundice (Option B): While hepatomegaly and jaundice can be present in pancreatic cancer, they are less specific. Hepatomegaly can occur due to a variety of other conditions, including liver metastasis. Murphy’s sign (Option D) is said to be positive when there is pain in right upper abdomen with deep palpation, classically seen in acute cholecystitis. Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 1282, 1283 https://www.ncbi.nlm.nih.gov/ books/NBK459171/#article-19448.s7:~:text=The%20finding%20of%20right%20upper%20abdominal%20pain%20 with%20deep%20palpation%2C%20Murphy%20sign%2C%20is%20usually%20classic%20for%20this%20disease .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 22,
      "question": "A 56-year-old patient with pancreatic cancer has completed initial treatment. To monitor for potential recurrence, the oncologist decides to check a tumor marker. Which of the following tumor markers is commonly used for establishing a baseline and monitoring for recurrence in pancreatic cancer?",
      "options": {
        "A": "Alpha-fetoprotein",
        "B": "Carbohydrate Antigen 19-9",
        "C": "Carcinoembryonic Antigen",
        "D": "Human Chorionic Gonadotropin"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Carbohydrate Antigen 19-9 Explanation: Carbohydrate Antigen 19-9 (CA19-9) is commonly used to establish a baseline level and monitoring for recurrence in pancreatic cancer. Pancreatic cancer tumor marker: Carbohydrate Antigen 19-9 (CA19-9) Usage : Establish a baseline level for monitoring. Characteristics : Not highly specific or sensitive. Useful for detecting recurrence if initial levels are raised Alpha-fetoprotein (AFP) (Option A) : Primarily useful for liver cancer and germ cell tumors, not specific to pancreatic cancer. Carcinoembryonic Antigen (CEA) (Option C) : More commonly used for colorectal cancer, not specifically for pancreatic cancer. Human Chorionic Gonadotropin (hCG) (Option D) : Primarily used in the context of trophoblastic diseases and certain germ cell tumors, not for pancreatic cancer. Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 1283,1284, 1571, 1572, 1364, 1618",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    },
    {
      "q_no": 23,
      "question": "A 65-year-old man presents with symptoms of jaundice and abdominal pain. Imaging studies reveal a solid mass in the pancreatic head. Histological examination shows a dense fibrous stroma with neoplastic tubular glands. The tumor is characterized by local spread along nerves, lymphatics, and blood vessels, and has metastasized to the liver. What is the most likely diagnosis?",
      "options": {
        "A": "Serous cystadenoma",
        "B": "Mucinous cystic neoplasm",
        "C": "Ductal adenocarcinoma",
        "D": "Solid pseudopapillary neoplasm"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Ductal adenocarcinoma Explanation: Ductal adenocarcinoma type of pancreatic cancer is characterized by a solid mass with neoplastic tubular glands in a dense fibrous stroma, local spread, and metastasis, as described in the given scenario. Ductal Adenocarcinoma (Option C) Prevalence : >85% of pancreatic cancer cases (most common) Origin : Ductal cells of the pancreas. Characteristics : Solid tumors with neoplastic tubular glands in dense fibrous stroma. Spread : Locally along nerves, lymphatics, and blood vessels; metastasis often to the liver and peritoneum. Challenges : Histological differentiation can be difficult due to similarities with chronic pancreatitis. Tumor Type Characteristics Common Locations Typical Patients Ductal Adenocarcinoma Solid tumors with neoplastic tubular glands Pancreas (general) - Serous Cystadenomas (Option A ruled put) Large clusters of small cysts Pancreas Older women Mucinous Cystic Neoplasms (Option B ruled out) Thick-walled, multilocular cysts Pancreatic body or tail Perimenopausal women Intraductal Papillary Mucinous Neoplasms (IPMNs) Multifocal, more likely malignant Pancreatic head Older men Solid Pseudopapillary Neoplasms (Option D ruled out) Large, partially solid, partially cystic masses Pancreas Women of childbearing age Adenomas of the Ampulla of Vater Smooth, polypoid submucosal masses Ampulla of Vater - Ampullary Adenocarcinomas Early presentation with biliary obstruction Ampulla of Vater - Reference: Bailey and Love Short Practice of Surgery, 28th Edition, Page 1281, 1282",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Hepatobiliary Pancreatic Surgery-Pancreatic Tumors"
    }
  ]
}
